Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FD782
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,646
Award facts
- Contract value 100% obligated
- $22,645.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,645.52 to AmerisourceBergen Drug Corp on January 21, 2026, with an ultimate completion date of January 22, 2026. This firm fixed-price contract, issued without a set-aside designation, represents a task order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical vendor for federal medical procurement needs, supplying a comprehensive range of products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare systems worldwide.
This delivery order reflects AmerisourceBergen's established role as a prime pharmaceutical vendor within the DLA's global medical supply chain. The company's parent organization, Cencora, Inc. (doing business as AmerisourceBergen), holds the overarching IDC with the Defense Logistics Agency and competes on a full and open basis for federal pharmaceutical contracts. The contract structure and award history demonstrate AmerisourceBergen's capability to efficiently fulfill government requirements for essential pharmaceutical commodities needed by military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The DLA Medical Supply Chain continues to leverage multiple contractors under its Pharmaceutical Prime Vendor Global Program, with AmerisourceBergen remaining a key supplier for federal medical procurement.
Quick answers
Who was awarded contract SPE2DU26FD782?
SPE2DU26FD782 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DU26FD782 worth?
The government has obligated $22,646 on SPE2DU26FD782.
Is contract SPE2DU26FD782 an order under another contract?
Yes. SPE2DU26FD782 is a delivery order under SPE2DU25D5137, an indefinite delivery contract.
Was contract SPE2DU26FD782 competed?
The extent of competition for SPE2DU26FD782 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award